Elevated NfL levels are a non-specific biomarker of neuroaxonal injury 17, while increased P-tau181 levels are associated with brain amyloid and tau burden, characteristic features of Alzheimer’s disease.46 These blood plasma biomarkers serve as important indicators of disease status and could help in the early detection of CIND/dementia. Here, MAPT is linked to Alzheimer disease.